Atherosclerosis: An update

American Heart Journal

Volumn 131, Issue 6, 1996, Pages 1192-1202

  Basha, Bassem Jamil ^a   Sowers, James R ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN B; SOMATOMEDIN C;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; HISTOPATHOLOGY; HUMAN; IMMUNOMODULATION; METABOLIC REGULATION; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0029997961     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90096-4     Document Type: Article

References (61)

1. American Heart Association. 1990 heart and stroke facts. Dallas, Texas: American Heart Association, 1990.
2. Hegele RA. Gene-environment interactions in atherosclerosis. Mol Cell Biochem 1992;113:177-86.
3. Multiple Risk Factor Intervention Trial Research Group. Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Prev Med 1986;15:254-73.
4. Castelli WP, Anderson K. A population at risk: prevalence of high cholesterol levels in hypertensive patients in the Framingham study. Am J Med 1986;80(suppl 2A):23-32.
5. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program II: mortality by race, sex and age. JAMA 1979;242:2572-7.
6. Oliver MF. What is the difference between women and men? In: Oliver MF, Vedin A, Wilhelmsson C, eds. Myocardial infarction in women. Edinburgh: Churchill Livingstone, 1986.
7. Castelli WP. The triglyceride issue: a view from Framingham. Am Heart J 1986;112:432-437.
8. Flag MJ, Ford DE, Mead LA, He J, Whelton PK, Liang KY, Levine DM. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 1993;328:313-18.
9. Kannel WB. Hypertension: relationship with other risk factors. Drugs 1986;31(suppl 1):1-11.
10. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968-77.
11. Kannel WB. Lipids, diabetes and coronary heart disease: insight from the Framingham study. Am Heart J 1985;110:1100-7.
12. Garrison RJ,. Kannel WB, Feinleib MP, Castelli WP, McNamara PM, Padgett SJ. Cigarette smoking and HDL-cholesterol: the Framingham offspring study. Atherosclerosis 1978;30:17-25.
13. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of CHD in an elderly cohort. The Framingham Heart Study. Ann Intern Med 1989;110:101-7.
14. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham study. JAMA 1986;256:2835-8.
15. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989;320:702-6.
16. Sowers JR. Insulin resistance, hyperinsulinemia, dyslipidemia, hypertension and accelerated atherosclerosis. J Clin Pharm 1992;32:529-35.
17. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary artery disease mortality in middle aged population. Diabetologia 1980;19:205-10.
18. Borch-Johnson K, Nissen RN, Nenup J. Blood pressure after 40 years of insulin dependent diabetes. Nephron 1985;4:11-2.
19. Zhu BQ, Sun YP, Sievers RE, Isenberg WM, Glantz SA, Parmley WW. Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol 1993;21:225-32.
20. Criqui MH, Browner D, Fronek A, Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease. An analysis of risk factors. Am J Epidemiol 1989;129:1110-9.
21. Yarnell JWG, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, Elwood PC. Fibrinogen, viscosity and white blood cell count are major risk factors for ischemic heart disease: the Caerphilly and Speedwell Collaborative Heart Disease studies. Circulation 1991; 83:836-44.
22. Grimm RH Jr, Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer and all cause mortality. JAMA 1985;254:1932-7.
23. Hajjar DP. Viral pathogenesis of atherosclerosis. Impact of molecular mimicry and viral genes. Am J Pathol 1991;139:1195-211.
24. Jain AK, Vargas R, Gotzkowsky. Can garlic reduce levels of serum lipids? A controlled clinical study. Am J Med 1993;94:632-5.
25. Esterbauer H, Puhl H, Diber-Rotheneder M, Waeg G, Rabl H. Effects of antioxidants on oxidative modification of LDL. Ann Med 1991;23:573-81.
26. Campbell GR, Campbell JH. Recent advances in molecular pathology: smooth muscle phenotypic changes in arterial wall homeostasis: implication for the pathogenesis of atherosclerosis. Exp Mol Pathol 1985;42: 139-62.
27. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med 1986;314:488-500.
28. Ross R. The pathogenesis of atherosclerosis. In: Braunwald E, ed. Heart disease: a textbook of cardiovascular medicine. 4th ed. Philadelphia, Penn: WB Saunders, 1991:1106-24.
29. Gordon D, Schwartz SM. Replication of arterial smooth muscle cells in hypertension and atherosclerosis. Am J Cardiol 1987;59:44-8A.
30. Hart CE, Forstrom JW, Kelly JD. Two classes of PDGF receptors recognize different isoforms of PDGF. Science 1988;240:1529-31.
31. Hirosumi J, Ouchi Y, Watanabe M, Kusunoki J, Nakamura T, Orimo H. Effects of growth factors on cytosolic free calcium concentration and DNA synthesis in cultured rat aortic SMCs. Tohoku J Exp Med 1989; 157:289-300.
32. Bell L, Madri JA. Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells. Circ Res 1989;65:1057-65.
33. Bornfeldt KE, Arngvist HJ, Norstedt G. Regulation of IGF-1 gene expression by growth factors in cultured vascular SMCs. J Endocrinol 1990;125:381-6.
34. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. PDGF promotes smooth muscle migration and intimai thickening in a rat model of balloon angioplasty. J Clin Invest 1992;89:507-11.
35. Thyberg J, Hedin U, Sjolund M, Palmberg L, Bottger BA. Regulation of differentiated properties and proliferation of arterial SMC. Arteriosclerosis 1990; 10:966-90.
36. Shimokado K, Raines EW, Madtes DK. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell 1985;43:277-86.
37. Ross R, Glomset J, Kariya B, Harker L. A platelet dependent serum factor that stimulates the proliferation of arterial SMCs in vitro. Proc Natl Acad Sci USA 1974;71:1207-10.
38. Schollmann C, Grugel R, Tatje D, Hoppe J, Folkman J, Marme D, Weich HA. bFGF modulates the mitogenic potency of the PDGF isoforms by specific up-regulation of the PDGF alpha receptor on vascular SMCs. J Biol Chem 1992;267:18032-9.
39. Blank RS, Owens GK. PDGF regulates actin isoform expression and growth state in cultured rat aortic SMC. J Cell Physiol 1990;142:635-42.
40. Sarzani R, Arnaldi G, Takasaki I, Brecher P, Chobanian AV. Effect of hypertension and aging on PDGF and PDGF receptor expression in rat aorta and heart. Hypertension 1991;18(suppl III):93-9.
41. Ferns GA, Motani AS, Äuggord EE. The IGFs: their putative role in atherogenesis. Artery 1991;18:197-225.
42. Murphy LJ, Ghahary A, Chakrabarti S. Insulin regulation of IGF-1 expression in rat aorta. Diabetes 1990;39:657-62.
43. Stout RW. Insulin as a mitogenic factor: role in the pathogenesis of cardiovascular disease. Am J Med 1991;90(suppl 2A);62S-5S.
44. Rich CB, Ewton DZ, Martin BM, Florini JR, Bashir M, Rosenbloom J, Foster JA. IGF-1 regulation of elastogenesis: comparison of aortic and lung cells. Am J Physiol 1992;263(Lung Cell Mol Physiol 7):L276-82.
45. Pfeifle B, Boeder H, Ditschuneit H. Interaction of receptors for IGF-1, PDGF, FGF in rat aortic cells. Endocrinology 1987;120:2251-8.
46. Sugimoto H, Franks DJ, Lecavalier L, Chiasson JL, Hamet P. Therapeutic modulation of growth promoting activity in platelets from diabetics. Diabetes 1987; 36:667-72.
47. Geffner ME, Bersch N, Nakamoto P, Scott M, Johnson NB, Golde DW. Use of in vitro clonogenic assays to differentiate acquired from genetic causes of insulin resistance. Diabetes 1991;40:28-36.
48. Jialal I, King GL, Buchwald S, Kahn Cr, Crettaz M. Processing of insulin by bovine endothelial cells in culture. Internalization without degradation. Diabetes 1984;33:794-800.
49. Hachiya HL, Carpentier JL, King GL. Comparative studies on IGF-2 and insulin processing by vascular endothelial cells. Diabetes 1986; 35:1065-72.
50. Scott-Burden T, Resnick TJ, Buhler FR. Growth regulation in SMC from normal and hypertensive rats. J Cardiovasc Pharmacol 1988; 12(suppl 5):S124-7.
51. Bukoski RD, DeWan P, Bo J. Mechanism of the enhanced EGF-induced growth response of genetically hypertensive vascular myocytes. Circ Res 1991;69:757-64.
52. Hadrava V, Tremblay J, Hamet P. Abnormalities in growth characteristics of aortic SMCs in SHR. Hypertension 1989;13:589-97.
53. Bjorkerud S: Effects of TGFβ on human arterial SMCs in vitro. Arterioscler Thromb 1991;11:892-902.
54. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes PK, Raines EW, Ross R, Sporn MB. Expression and secretion of type β TGF by activated human macrophages. Proc Natl Acad Sci USA 1987;84: 6020-4.
55. Assoian RK, Komoriya A, Meyers CA, Miller DM, Spron MB. Transforming growth factor-β in human platelets: identification of a major storage site, purification, and characterization. J Biol Chem 1983;258: 7155-60.
56. Owens GK, Geisterfer AA, Yang YW, Komoriya A. TGFβ-induced growth inhibition and cellular hypertrophy in cultured vascular SMCs. J Cell Biol 1988;107:771-80.
57. Masson P, Malark M, Sawada H, Kan M, McKeehan WL. Heparin binding (fibroblast) growth factors types 1,2 genes are coexpressed in proliferating normal human vascular endothelial and smooth muscle cells in culture. In Vitro Cell Dev Biol 1990;26:209-12.
58. Chamley-Campbell J, Campbell GR, Ross R. The smooth muscle cell in culture. Physiol Rev 1979;59(1):1-61.
59. Gutstein WH. The CNS and atherogenesis: role of the arterial smooth muscle cell atherosclerosis. 1990;82(1-2):145-55.
60. Lonchampt MO, Pinelis S, Goulin J, Chabrier PE, Braquet P. Proliferation and Na/H exchange activation by endothelin in vascular SMC. Am J Hypertens 1991;4:776-9.
61. Berk BC, Elder E, Mitsuka M. Hypertrophy and hyperplasia cause differing effects on vascular SMC Na/H exchange and intracellular pH. J Biol Chem 1990;265(32):19632-7.